Review article for Cardiovascular Drugs and Therapy (Springer Nature), March 2026
-
Journal paper for BMC Cardiovascular Diabetology (Springer Nature), December 2025, updated May 2026
-
Journal paper for Aging and Disease, June 2026
-
Review article for Karger Obesity Facts, June 2026
-
Journal paper for BMC Medical Research Methodology (Springer Nature), June 2026
Proteomic & genomic electrochemical sensors, microfluidic cartridges, sample preparation technologies and user instrumentation
The clinical, biochemical and genetic data generated in the PoCCardio clinical trial are used to develop a computational AI-based tool for predicting the risk of a heart attack and therapy response in patients.
13 out of 29 study centres in Austria, Germany and Poland have begun recruiting participants for the trial of the PoCCardio point-of-care solution.
-
The paper was prepared by the Medical University of Graz for the CIBB 2024 conference on Computational Intelligence methods for Bioinformatics and Biostatistics.
PoCCardio welcomes the Bioinformatics Department at CING - The Cyprus Institute of Neurology and Genetics
PoCCardio is funded by the European Union’s Horizon Europe Framework Programme for Research and Innovation under Grant Agreement no. 101095432
© Copyright 2023 – | The PoCCardio Project | All Rights Reserved